Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis : a cross-sectional study using the central sensitisation inventory
OBJECTIVES: Several studies have indicated that arthralgia may be driven by central sensitisation. Central sensitivity syndrome (CSS) is a concept that unifies various symptoms due to central sensitisation. Recently, the central sensitisation inventory (CSI) was developed as a screening questionnaire to detect CSS. Using the CSI, we examined the prevalence, the clinical characteristics of CSS, and the association between CSS and neuropathic pain (NP)-like symptoms among rheumatoid arthritis (RA) patients.
METHODS: The CSI was administered to 240 RA outpatients. We evaluated their disease activity and several potentially relevant patient-reported outcomes. We compared the clinical parameters depending on the severity of CSS and examined the effect of the CSI score on NP-like symptoms among the relevant clinical parameters using multivariate analyses.
RESULTS: The mean disease duration was 9.58 ± 7.76 years. Eighteen (7.5 %) patients had CSS, which was associated with evaluator global assessment (EGA) (odds ratio (OR) 0.860); fibromyalgia symptom scale (OR 1.46); painDETECT questionnaire score (OR 1.24); hospital anxiety and depression scale-anxiety (OR 1.35); and physical (OR 0.898), mental (OR 0.828), and role-social (OR 0.946) component summary scores on the Short-Form 36-Item Health Survey. CSI score was the factor that contributed most to NP-like symptoms (p=0.000, β=0.266).
CONCLUSIONS: NP-like symptoms might be one of the symptoms of CSS in longstanding RA patients. In longstanding RA patients who have disproportionately greater NP-like symptoms and/or widespread pain compared with degree of inflammation, detecting CSS using CSI might help to understand the pathogenesis of patients.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:40 |
---|---|
Enthalten in: |
Clinical and experimental rheumatology - 40(2022), 5 vom: 10. Mai, Seite 980-987 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Saitou, Moe [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Completed 19.05.2022 Date Revised 19.05.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.55563/clinexprheumatol/msy022 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM326765093 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM326765093 | ||
003 | DE-627 | ||
005 | 20231225195313.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.55563/clinexprheumatol/msy022 |2 doi | |
028 | 5 | 2 | |a pubmed24n1089.xml |
035 | |a (DE-627)NLM326765093 | ||
035 | |a (NLM)34128802 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Saitou, Moe |e verfasserin |4 aut | |
245 | 1 | 0 | |a Central sensitisation features are associated with neuropathic pain-like symptoms in patients with longstanding rheumatoid arthritis |b a cross-sectional study using the central sensitisation inventory |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 19.05.2022 | ||
500 | |a Date Revised 19.05.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a OBJECTIVES: Several studies have indicated that arthralgia may be driven by central sensitisation. Central sensitivity syndrome (CSS) is a concept that unifies various symptoms due to central sensitisation. Recently, the central sensitisation inventory (CSI) was developed as a screening questionnaire to detect CSS. Using the CSI, we examined the prevalence, the clinical characteristics of CSS, and the association between CSS and neuropathic pain (NP)-like symptoms among rheumatoid arthritis (RA) patients | ||
520 | |a METHODS: The CSI was administered to 240 RA outpatients. We evaluated their disease activity and several potentially relevant patient-reported outcomes. We compared the clinical parameters depending on the severity of CSS and examined the effect of the CSI score on NP-like symptoms among the relevant clinical parameters using multivariate analyses | ||
520 | |a RESULTS: The mean disease duration was 9.58 ± 7.76 years. Eighteen (7.5 %) patients had CSS, which was associated with evaluator global assessment (EGA) (odds ratio (OR) 0.860); fibromyalgia symptom scale (OR 1.46); painDETECT questionnaire score (OR 1.24); hospital anxiety and depression scale-anxiety (OR 1.35); and physical (OR 0.898), mental (OR 0.828), and role-social (OR 0.946) component summary scores on the Short-Form 36-Item Health Survey. CSI score was the factor that contributed most to NP-like symptoms (p=0.000, β=0.266) | ||
520 | |a CONCLUSIONS: NP-like symptoms might be one of the symptoms of CSS in longstanding RA patients. In longstanding RA patients who have disproportionately greater NP-like symptoms and/or widespread pain compared with degree of inflammation, detecting CSS using CSI might help to understand the pathogenesis of patients | ||
650 | 4 | |a Journal Article | |
700 | 1 | |a Noda, Kentaro |e verfasserin |4 aut | |
700 | 1 | |a Matsushita, Takayuki |e verfasserin |4 aut | |
700 | 1 | |a Ukichi, Taro |e verfasserin |4 aut | |
700 | 1 | |a Kurosaka, Daitaro |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Clinical and experimental rheumatology |d 1989 |g 40(2022), 5 vom: 10. Mai, Seite 980-987 |w (DE-627)NLM012613010 |x 0392-856X |7 nnns |
773 | 1 | 8 | |g volume:40 |g year:2022 |g number:5 |g day:10 |g month:05 |g pages:980-987 |
856 | 4 | 0 | |u http://dx.doi.org/10.55563/clinexprheumatol/msy022 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 40 |j 2022 |e 5 |b 10 |c 05 |h 980-987 |